Quo vadis collateral blood flow?: A commentary on a highly cited paper

Cardiovascular Research

Volumn 45, Issue 1, 2000, Pages 220-223

  Schaper, Wolfgang ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Blood flow; Collateral circulation; Coronary circulation; Coronary disease; Infarction; Ischemia

Indexed keywords

ALTEPLASE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; COLLATERAL CIRCULATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEMODYNAMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE;

ANIMALS; COLLATERAL CIRCULATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 0033990629     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00332-6     Document Type: Review

References (25)

1. Maxwell M.P., Hearse D.J., Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 21:1987;737-746.
2. Factor S.M., Sonnenblick E.H., Kirk E.S. Histological border zone of acute myocardial infarction: islands or peninsulas? Circulation. 56:1977;III-71.
3. Reimer K.A., Lowe J.E., Rasmussen M.M., Jennings R.B. The 'wavefront phenomenon' of ischemic cell death. I. Myocardial infarct size versus duration of coronary occlusion in dogs. Circulation. 56:1977;786-794.
4. Schaper W. Experimental infarcts and the microcirculation. Hearse D.J., Yellon D.M. Therapeutic approaches to myocardial infarct size limitation. 1984;79-90 Raven Press, New York.
5. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
6. Mũller K.D., Klein H., Schaper W. Changes in myocardial oxygen consumption 45 min after experimental coronary occlusion do not alter infarct size. Cardiovasc Res. 14:1980;710-718.
7. Van der Laarse A., Vermeer F., Hermens W.T., Simoons M.L. Effect of early intracoronary streptokinase on extent and rate of development of enzymatic infarct size. Europ Heart J. 6:1985;264.
8. Schaper W., Binz K., Sass S., Winkler B. Influence of collateral blood flow and of variations in MVO2 on tissue-ATP content in ischemic and infarcted myocardium. J Mol Cell Cardiol. 19:1987;19-37.
9. Schultz J.E.J., Hsu A.K., Nagase H., Gross G.J. TAN-67, a delta(1)-opioid receptor agonist, reduces infarct size via activation of G(II0) proteins and K-ATP channels. Am J Physiol. 43:1998;H909-H914.
10. Jaye M., Howk R., Burgess W., et al. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science. 233:1986;541-545.
11. Quinkler W., Maasberg M., Bernotat-Danielowski S., et al. Isolation of heparin binding growth factors from bovine, porcine, and canine hearts. Eur J Biochem. 181:1989;67-73.
12. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
13. Cohen M.V., Downey J.M. Ischemic preconditioning: can the protection be bottled? The Lancet. 342:1993;6.
14. Risau W. Angiogenesis. Arzneimittel-Forschung/Drug Research 1994;44(I)(3a): 416-417.
15. Risau W., Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 11:1995;73-91.
16. Schaper W., Piek J.J., Munoz-Chapuli R., Wolf C., Ito W. Collateral circulation of the heart. Ware J.A., Simons M. Angiogenesis and cardiovascular disease. 1999;159-198 Oxford University Press, New York, NY, Oxford.
17. Schaper W., Sharma H.S., Quinkler W., et al. Molecular biologic concepts of coronary anastomoses. J Am Coll Cardiol. 15:1990;513-518.
18. Ikeda E., Achen M.G., Breier G., Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem. 270:1995;19761-19766.
19. Lazarous D.F., Scheinowitz M., Shou M., et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 91:1995;145-153.
20. Banai S., Jaklitsch M.D., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
21. Schwarz ER, Kioner RA. Direkte Applikation der DNA für vascular endothelial growth factor (VEGF) in die Randbereiche infarzierten Myokards induziert Angiogenese ohne Verbesserung der regionalen Myokardperfusion bei Ratten. In: Z Kardiol. 1999:675 (abstr);88 (Suppl 1)).
22. Henry TD, Annex BH, Azrin MA. et al. Double Blind, Placebo Controlled Trial of Recombinant Human Vascular Endothelial Growth Factor - The Viva Trial. In: JACC 1999:33A;384A.
23. Schaper W., Koenig R., Franz D., Schaper J. Scanning electron microscopy of developing coronary arterial blood vessels. Ben-Shaul J. Electron Microscopy, Proc 6th Europ Congress on Electron Microscopy. 1976;438-440 Tal International Publishing Company, Israel.
24. Leibovich S.J., Polverini P.J., Shepard H.M., et al. Macrophageinduced angiogenesis is mediated by tumor necrosis factor-α Nature. 329:1987;630-632.
25. Arras M., Ito W.D., Scholz D., et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 101:(1):1998;41-50.